• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名37岁纹状体淀粉样蛋白显著潴留的阿尔茨海默病患者的病例报告。

A Case Report of a 37-Year-Old Alzheimer's Disease Patient with Prominent Striatum Amyloid Retention.

作者信息

Um Yoo Hyun, Choi Woo Hee, Jung Won Sang, Park Young Ha, Lee Chang-Uk, Lim Hyun Kook

机构信息

Department of Psychiatry, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Department of Radiology, Division of Nuclear Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Republic of Korea.

出版信息

Psychiatry Investig. 2017 Jul;14(4):521-524. doi: 10.4306/pi.2017.14.4.521. Epub 2017 Jul 11.

DOI:10.4306/pi.2017.14.4.521
PMID:28845182
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5561413/
Abstract

With recent advancement in amyloid imaging, diagnostic application of this new modality has become a great interest among researchers. New ligands, such as 18F- florbetaben, florbetapir and flutemetamol, have been discovered to overcome limitations of preexisting ligand Pittsburgh compound B. We report here a case of a 37-year-old male patient whose initial complaints comprised of gradual cognitive decline, apraxia, disorientation and sleep disturbances. 18F-Florbetaben amyloid imaging of the patient showed diffuse amyloid retention with prominent striatal uptake. This finding supports the clinical utility of amyloid imaging in diagnostic process of early-onset AD. Moreover, striatal dominant uptake pattern demonstrated in this patient include some meaningful clinical implications that warrant special attention among clinicians.

摘要

随着淀粉样蛋白成像技术的最新进展,这种新方法的诊断应用已引起研究人员的极大兴趣。已发现新的配体,如18F-氟贝他班、氟代匹哌酸和氟美他莫,以克服先前存在的配体匹兹堡化合物B的局限性。我们在此报告一例37岁男性患者,其最初症状包括逐渐认知衰退、失用症、定向障碍和睡眠障碍。该患者的18F-氟贝他班淀粉样蛋白成像显示弥漫性淀粉样蛋白滞留,并伴有明显的纹状体摄取。这一发现支持了淀粉样蛋白成像在早发性阿尔茨海默病诊断过程中的临床应用价值。此外,该患者显示的纹状体优势摄取模式具有一些有意义的临床意义,值得临床医生特别关注。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f8d/5561413/ba1c438a2f96/pi-14-521-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f8d/5561413/ba1c438a2f96/pi-14-521-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f8d/5561413/ba1c438a2f96/pi-14-521-g001.jpg

相似文献

1
A Case Report of a 37-Year-Old Alzheimer's Disease Patient with Prominent Striatum Amyloid Retention.一名37岁纹状体淀粉样蛋白显著潴留的阿尔茨海默病患者的病例报告。
Psychiatry Investig. 2017 Jul;14(4):521-524. doi: 10.4306/pi.2017.14.4.521. Epub 2017 Jul 11.
2
Prominent Striatum Amyloid Retention in Early-Onset Familial Alzheimer's Disease With PSEN1 Mutations: A Pilot PET/MR Study.早发性家族性阿尔茨海默病伴PSEN1突变患者纹状体显著的淀粉样蛋白滞留:一项PET/MR初步研究
Front Aging Neurosci. 2021 Sep 15;13:732159. doi: 10.3389/fnagi.2021.732159. eCollection 2021.
3
Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.常染色体显性遗传性阿尔茨海默病中星形细胞增生和淀粉样蛋白PET的纵向变化差异
Brain. 2016 Mar;139(Pt 3):922-36. doi: 10.1093/brain/awv404. Epub 2016 Jan 26.
4
Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.[11C]匹兹堡化合物B(PiB)与[18F]氟代甲磺酸去甲替林在正常对照者和阿尔茨海默病患者中的定性和定量成像特征比较。
Neuroimage Clin. 2015 Oct 14;9:592-8. doi: 10.1016/j.nicl.2015.10.007. eCollection 2015.
5
A systematic review and meta-analysis of (18)F-labeled amyloid imaging in Alzheimer's disease.(18)F标记淀粉样蛋白成像在阿尔茨海默病中的系统评价与荟萃分析
Alzheimers Dement (Amst). 2015 Mar 29;1(1):5-13. doi: 10.1016/j.dadm.2014.11.004. eCollection 2015 Mar.
6
Detection of Striatal Amyloid Plaques with [18F]flutemetamol: Validation with Postmortem Histopathology.用[18F]氟美妥莫尔检测纹状体淀粉样斑块:与尸检组织病理学对照验证
J Alzheimers Dis. 2016 Mar 31;52(3):863-73. doi: 10.3233/JAD-150732.
7
Imaging β-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis.使用[18F]氟替美莫正电子发射断层扫描成像β-淀粉样蛋白:从剂量测定到临床诊断
Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):362-373. doi: 10.1007/s00259-015-3208-1. Epub 2015 Oct 6.
8
Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.阿尔茨海默病成像生物标志物的比较:使用[18F]氟比他哌正电子发射断层扫描进行淀粉样蛋白成像以及对内嗅皮质萎缩进行基于磁共振成像体素的分析。
Int J Geriatr Psychiatry. 2015 May;30(5):505-13. doi: 10.1002/gps.4173. Epub 2014 Jul 7.
9
Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.使用 18F-THK5105 PET 进行阿尔茨海默病神经纤维缠结的无创评估。
Brain. 2014 Jun;137(Pt 6):1762-71. doi: 10.1093/brain/awu064. Epub 2014 Mar 27.
10
Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals.tau 沉积与正常和早期有症状个体中淀粉样-β 积累率的关系。
Brain. 2017 May 1;140(5):1499-1512. doi: 10.1093/brain/awx046.

引用本文的文献

1
The striatum is an early, accurate indicator of amyloid burden using [C]PiB in Down syndrome: Comparison of two radiotracers.在唐氏综合征中,纹状体是使用[C]PiB检测淀粉样蛋白负荷的早期、准确指标:两种放射性示踪剂的比较。
Alzheimers Dement. 2025 Apr;21(4):e70141. doi: 10.1002/alz.70141.
2
The striatum is an early, accurate indicator of amyloid burden using [C]PiB in Down syndrome: comparison of two radiotracers.纹状体是唐氏综合征中使用[C]匹兹堡化合物B(PiB)检测淀粉样蛋白负荷的早期准确指标:两种放射性示踪剂的比较。
medRxiv. 2024 Dec 6:2024.12.04.24318526. doi: 10.1101/2024.12.04.24318526.
3
Striatal amyloid is associated with tauopathy and memory decline in familial Alzheimer's disease.

本文引用的文献

1
Dissociation of Down syndrome and Alzheimer's disease effects with imaging.通过影像学对唐氏综合征与阿尔茨海默病效应进行解离研究。
Alzheimers Dement (N Y). 2016 Jun;2(2):69-81. doi: 10.1016/j.trci.2016.02.004.
2
Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers.淀粉样蛋白PET成像在非典型痴呆鉴别诊断中的临床应用及其对护理人员的影响。
J Alzheimers Dis. 2016 Apr 18;52(4):1251-62. doi: 10.3233/JAD-151180.
3
The amyloid hypothesis of Alzheimer's disease at 25 years.阿尔茨海默病淀粉样蛋白假说25年回顾
纹状体淀粉样蛋白与家族性阿尔茨海默病中的 tau 病和记忆下降有关。
Alzheimers Res Ther. 2019 Feb 4;11(1):17. doi: 10.1186/s13195-019-0468-1.
4
Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer's disease from late-onset amyloid deposition.早期纹状体淀粉样蛋白沉积可将唐氏综合征和常染色体显性阿尔茨海默病与晚发性淀粉样蛋白沉积区分开来。
Alzheimers Dement. 2018 Jun;14(6):743-750. doi: 10.1016/j.jalz.2018.01.002. Epub 2018 Mar 1.
EMBO Mol Med. 2016 Jun 1;8(6):595-608. doi: 10.15252/emmm.201606210. Print 2016 Jun.
4
The effects of normal aging on amyloid-β deposition in nondemented adults with Down syndrome as imaged by carbon 11-labeled Pittsburgh compound B.用碳11标记的匹兹堡化合物B成像,正常衰老对非痴呆唐氏综合征成年人β淀粉样蛋白沉积的影响。
Alzheimers Dement. 2016 Apr;12(4):380-90. doi: 10.1016/j.jalz.2015.05.013. Epub 2015 Jun 13.
5
Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia.在患有和未患阿尔茨海默病痴呆症的唐氏综合征个体中进行的氟代硼吡咯正电子发射断层扫描(Florbetapir PET)、氟脱氧葡萄糖正电子发射断层扫描(FDG PET)和磁共振成像(MRI)。
Alzheimers Dement. 2015 Aug;11(8):994-1004. doi: 10.1016/j.jalz.2015.01.006. Epub 2015 Apr 4.
6
Beta-amyloid imaging with florbetaben.使用氟比他班进行β-淀粉样蛋白成像。
Clin Transl Imaging. 2015;3(1):13-26. doi: 10.1007/s40336-015-0102-6. Epub 2015 Feb 12.
7
The translational journey of brain β-amyloid imaging: from positron emission tomography to autopsy to clinic.脑β-淀粉样蛋白成像的转化历程:从正电子发射断层扫描到尸检再到临床应用。
JAMA Neurol. 2015 Mar;72(3):265-6. doi: 10.1001/jamaneurol.2014.4143.
8
Age dependence of brain β-amyloid deposition in Down syndrome: An [18F]florbetaben PET study.唐氏综合征患者脑β-淀粉样蛋白沉积的年龄依赖性:一项[18F]氟比他班PET研究。
Neurology. 2015 Feb 3;84(5):500-7. doi: 10.1212/WNL.0000000000001212. Epub 2015 Jan 7.
9
Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer's disease.在散发型和家族性阿尔茨海默病中,突触标志物和 APP 的区域分布与不同的临床病理特征相关。
Brain. 2014 May;137(Pt 5):1533-49. doi: 10.1093/brain/awu046. Epub 2014 Mar 12.
10
Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association.适宜的淀粉样蛋白 PET 使用标准:淀粉样蛋白成像工作组、核医学与分子成像学会以及阿尔茨海默病协会的报告。
J Nucl Med. 2013 Mar;54(3):476-90. doi: 10.2967/jnumed.113.120618. Epub 2013 Jan 28.